Skip to main content
HYEX
NASDAQ Life Sciences

Healthy Extracts Reports Record 45% Revenue Surge to $4.5M in 2025, Achieves Non-GAAP Profitability

feedReported by Access Newswire
Sentiment info
Positive
Importance info
8
Price
$2.517
Mkt Cap
$42.464M
52W Low
$0.805
52W High
$7.2
Market data snapshot near publication time

summarizeSummary

Healthy Extracts Inc. (HYEX) announced audited full-year 2025 results, reporting a record 45% increase in net revenue to $4.5 million. The company also achieved non-GAAP net income of $162,000, or $0.02 per share, marking a significant financial turnaround from a GAAP net loss. This substantial growth was primarily fueled by the strategic merger with Gummy USA, continued technological innovation, product line and distribution channel expansion, and strengthening direct-to-consumer and retail sales. The results highlight strong operational momentum and successful integration of recent acquisitions, positioning HYEX for continued growth. Investors will be watching for further details on the impact of new product launches and the expanded partnership with Gelteq (GELS) for North American manufacturing.

At the time of this announcement, HYEX was trading at $2.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $42.5M. The 52-week trading range was $0.81 to $7.20. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Access Newswire.


show_chartPrice Chart

Share this article

Copied!

feed HYEX - Latest Insights

HYEX
Apr 16, 2026, 8:35 AM EDT
Source: Access Newswire
Importance Score:
8
HYEX
Apr 08, 2026, 6:38 PM EDT
Filing Type: 10-K
Importance Score:
9
HYEX
Apr 08, 2026, 4:05 PM EDT
Source: Access Newswire
Importance Score:
8
HYEX
Apr 02, 2026, 6:55 AM EDT
Source: Access Newswire
Importance Score:
8